Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Recent progress in shigella and burkholderia pseudomallei vaccines
Itziar Chapartegui-González
, Sarah Bowser
,
Alfredo G. Torres
, Nittaya Khakhum
Microbiology And Immunology
Research output
:
Contribution to journal
›
Article
›
peer-review
8
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Recent progress in shigella and burkholderia pseudomallei vaccines'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Burkholderia Pseudomallei
100%
Shigella
100%
T Cell Response
50%
Preventive Vaccine
50%
Developing Nations
50%
Infectious Process
50%
Intracellular Pathogen
50%
Vaccine Antigen
50%
Protective Antigen
50%
Vaccine Development
50%
Clinical Trials
50%
Intracellular Bacteria
50%
Infection Process
50%
Vaccine Platform
50%
Bacterial Infection
50%
Infectious Agents
50%
Intracellular Bacterial Pathogens
50%
Bacterial Pathogens
50%
Melioidosis
50%
Bacillary Dysentery
50%
Effective Rate of Protection
50%
Common Strategies
50%
Medicine and Dentistry
Pathogen
100%
Burkholderia pseudomallei
100%
Shigella
100%
Clinical Trial
33%
Infection
33%
T-Cell Response
33%
Bacterial Infection
33%
Melioidosis
33%
Bacillary Dysentery
33%
Pharmacology, Toxicology and Pharmaceutical Science
Infectious Agent
100%
Burkholderia pseudomallei
100%
Shigella
100%
Clinical Trial
25%
Infection
25%
Intracellular Bacterium
25%
Bacterial Infection
25%
Melioidosis
25%
Shigellosis
25%
Immunology and Microbiology
Infectious Agent
100%
Burkholderia pseudomallei
100%
Shigella
100%
Infection
50%
T Cell
25%
Intracellular Bacterium
25%